Filter

41 - 50 of 342 Results

  • How Could FDA’s New Guidance Affect COVID-19 Vaccination Coverage in the U.S.?

    Quick Take

    Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.

  • The Sad State of Trust in the CDC and FDA

    From Drew Altman

    In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

  • As COVID-19 Divisions, Attacks, and Misinformation Take Their Toll, Less Than Half of the Public Is Confident That the CDC and FDA Can Carry Out Core Functions 

    News Release

    Five years after the start of  COVID-19 pandemic and the communications challenges, divisions, and false claims that followed, less than half of the public say they have at least some confidence in the federal government’s health agencies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) to carry…

  • KFF Tracking Poll on Health Information and Trust: Vaccine Safety and Trust

    Poll Finding

    As the Trump administration overhauls government health agencies, partisan trust in these agencies on vaccines has shifted and few express confidence in their ability to carry out key tasks. Most adults are confident in the safety of routine vaccines, but the COVID-19 vaccines remain polarizing with many uncertain about false claims regarding mRNA technology.

  • Examining Short-Term Limited-Duration Health Plans on the Eve of ACA Marketplace Open Enrollment

    Issue Brief

    As Marketplace Open Enrollment nears, policy changes could leave millions of people facing substantially higher premiums and coverage loss, which could lead more consumers to purchase less expensive and less comprehensive coverage through short-term health plans. KFF analyzes short-term health policies sold by nine large insurers in 36 states, examining premiums, cost sharing, covered benefits, and coverage limitations and comparing them to ACA Marketplace plans.

  • KFF Tracking Poll on Health Information and Trust: Tylenol-Autism Link and Vaccine Policies

    Poll Finding

    Following the Trump administration’s warning last month that using acetaminophen – the active ingredient in Tylenol – during pregnancy can increase the risk of autism in children, very few adults say the claim about a causal relationship is “definitely true,” though much of the public is uncertain whether to believe it. Trust in the CDC to provide reliable vaccine information has fallen to a new low.

  • KFF Tracking Poll on Health Information and Trust: COVID-19 Vaccine Update

    Feature

    As federal vaccine policy changes, this poll finds that most adults do not expect to get a COVID-19 vaccine this fall , and many parents are confused and uncertain about whether the vaccine is recommended for healthy children this year. About one in five adults nationally say the changes to vaccine policy are making people safer, while more than a third say they are making people less safe.

  • Measles Elimination Status: What It Is and How the U.S. Could Lose It

    Policy Watch

    This policy watch post examines the United States’ measles elimination status, including what it means to eliminate measles, whether the current measles outbreak could threaten the country’s measles elimination status, and what losing that status might mean for measles control.